Schwab Charles Investment Management Inc. cut its stake in shares of Fluidigm Corporation (NASDAQ:FLDM) by 24.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 75,735 shares of the medical research company’s stock after selling 24,150 shares during the quarter. Schwab Charles Investment Management Inc. owned approximately 0.26% of Fluidigm Corporation worth $431,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. American International Group Inc. increased its holdings in Fluidigm Corporation by 7.1% during the first quarter. American International Group Inc. now owns 17,907 shares of the medical research company’s stock valued at $102,000 after buying an additional 1,187 shares during the period. Wells Fargo & Company MN increased its holdings in Fluidigm Corporation by 15.0% during the first quarter. Wells Fargo & Company MN now owns 25,521 shares of the medical research company’s stock valued at $146,000 after buying an additional 3,327 shares during the period. Bank of New York Mellon Corp grew its holdings in Fluidigm Corporation by 20.5% in the first quarter. Bank of New York Mellon Corp now owns 206,578 shares of the medical research company’s stock worth $1,175,000 after purchasing an additional 35,176 shares during the last quarter. Geode Capital Management LLC grew its holdings in Fluidigm Corporation by 1.5% in the first quarter. Geode Capital Management LLC now owns 218,321 shares of the medical research company’s stock worth $1,242,000 after purchasing an additional 3,311 shares during the last quarter. Finally, Acadian Asset Management LLC grew its holdings in Fluidigm Corporation by 46.0% in the first quarter. Acadian Asset Management LLC now owns 301,705 shares of the medical research company’s stock worth $1,716,000 after purchasing an additional 95,056 shares during the last quarter. 88.90% of the stock is currently owned by institutional investors and hedge funds.
In other Fluidigm Corporation news, insider Steven Mcphail purchased 20,000 shares of the business’s stock in a transaction on Tuesday, August 8th. The stock was bought at an average cost of $3.00 per share, with a total value of $60,000.00. Following the acquisition, the insider now owns 27,842 shares of the company’s stock, valued at $83,526. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Levin Capital Strategies, L.P. purchased 4,003,129 shares of the business’s stock in a transaction on Thursday, August 10th. The stock was acquired at an average cost of $3.30 per share, with a total value of $13,210,325.70. The disclosure for this purchase can be found here. Insiders acquired a total of 4,166,038 shares of company stock valued at $13,811,083 over the last three months. 4.70% of the stock is owned by corporate insiders.
FLDM has been the topic of several analyst reports. ValuEngine lowered shares of Fluidigm Corporation from a “sell” rating to a “strong sell” rating in a report on Friday, June 2nd. Zacks Investment Research raised shares of Fluidigm Corporation from a “sell” rating to a “hold” rating in a report on Thursday, June 1st.
TRADEMARK VIOLATION WARNING: This news story was posted by BBNS and is the sole property of of BBNS. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://baseballnewssource.com/markets/fluidigm-corporation-fldm-holdings-trimmed-by-schwab-charles-investment-management-inc/1604233.html.
Fluidigm Corporation (NASDAQ:FLDM) traded down 2.66% during midday trading on Friday, hitting $5.12. 180,204 shares of the stock traded hands. Fluidigm Corporation has a one year low of $2.52 and a one year high of $8.82. The stock’s market cap is $150.60 million. The company has a 50-day moving average price of $4.04 and a 200 day moving average price of $4.62.
Fluidigm Corporation (NASDAQ:FLDM) last posted its quarterly earnings data on Thursday, August 3rd. The medical research company reported ($0.58) earnings per share for the quarter, topping the consensus estimate of ($0.60) by $0.02. The business had revenue of $23.90 million during the quarter, compared to the consensus estimate of $23.50 million. Fluidigm Corporation had a negative net margin of 74.05% and a negative return on equity of 121.04%. The company’s quarterly revenue was down 15.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.63) earnings per share. Equities research analysts anticipate that Fluidigm Corporation will post ($2.13) earnings per share for the current year.
Fluidigm Corporation Company Profile
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.
Receive News & Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related companies with our FREE daily email newsletter.